Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostacyclin for vasospasm in SAH
NCT01447095Phase 2Completed
- Start
- Oct 2011
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epoprostenol in subarachnoid hemorrhage (SAH) (3 arms). Primary endpoint: Radiographic vasospasm measured by CT perfusion at Day 8. Started Oct 2011; status: completed.
02
Drugs
epoprostenol
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT01447095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447095.